Spartan Fund Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-191,063
Closed -$1.92M 400
2022
Q4
$1.92M Buy
+191,063
New +$1.9M 0.69% 47

Other funds holding AONC

Spartan Fund Management's AONC Position: Q1 2023 in Review

Spartan Fund Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 191,063 shares — an estimated $1.92M sold.

Spartan Fund Management first reported a position in AONC in Q4 2022 and held it in 1 quarter. The position peaked at $1.92M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Spartan Fund Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Spartan Fund Management sold 191,063 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.92M.
  • Spartan Fund Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Spartan Fund Management's American Oncology Network, Inc. Class A Common Stock position peaked at $1.92M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Spartan Fund Management's 13F filing for Q1 2023, filed 9 May 2023.